Dexcom Inc Q2 2021 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : I want to congratulate you guys on a really nice quarter. If I can ask, I think we're all interested in updated G7 approval timing sounds like you haven't filed in the U.S. yet. And you had a great international number. I'd love if you could provide just any examples or tangible examples of how the expansion of benefit is already helping you? And how it might continue to help you the rest of this year and next year?

Question: Mathew Justin Blackman - Stifel, Nicolaus & Company, Incorporated, Research Division - Analyst : Jereme, I just was curious about the second half cadence and whether we should be thinking about sort of a typical third quarter or fourth quarter cadence? Or are we sort of at the point or approaching the point where things like increasing pharmacy access may make the year somewhat less 4Q weighted as we've seen historically? Any help there would be appreciated.

Question: Travis Lee Steed - Barclays Bank PLC, Research Division - Analyst : Congratulations on a good quarter. I know you talked about the OUS launch of G7 here in the back half. And just curious if you could put some context on expectations for how we should think about that launch? And which countries if you're willing to share that? And you've also got probably 40 million to 50 million G6 sensors that you're making a year. And just curious what you're going to do with the G6 capacity as G7 launches?

Question: Ravi Misra - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : Just on the DexCom API. Can you talk a little bit about how you chose some of the partners that you're working with? I understand Livongo, of course, but with Garmin. And then just more on that. Just walk us through kind of how you envision this being separate or integrated with CLARITY in the future? Just curious why this is for industry rather than kind of providers itself?